Melanoma Margins Trial (MelMarT): A Phase III, multi-centre, multi-national randominsed control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma (ACTRN12614000667617)
MelMarT
This trial is Currently recruiting
Registration number ACTRN12614000667617
Program & service
This trial is being run with the Cancer service, and as part of the Victorian Melanoma Service program.
Trial phase
Phase 3
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Associate Professor Frank Bruscino-Raiola
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.